Intellia Therapeutics Correlations

NTLA Stock

USD 13.80 0.68 5.18%

The current 90-days correlation between Intellia Therapeutics and Editas Medicine is 0.38 (i.e., Weak diversification). The correlation of Intellia Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Intellia Therapeutics Correlation With Market

Very weak diversification

The correlation between Intellia Therapeutics and DJI is 0.49 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Intellia Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Intellia Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For information on how to trade Intellia Stock refer to our How to Trade Intellia Stock guide.

Moving together with Intellia Stock

0.78	DYN	Dyne Therapeutics	Pair Corr
0.79	XFOR	X4 Pharmaceuticals	Pair Corr
0.71	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.89	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.68	PFE	Pfizer Inc Fiscal Year End 4th of February 2025	Pair Corr
0.82	INZY	Inozyme Pharma	Pair Corr
0.87	KURA	Kura Oncology	Pair Corr
0.76	PALI	Palisade Bio	Pair Corr
0.77	BDRX	Biodexa Pharmaceticals Upward Rally	Pair Corr
0.63	TERN	Terns Pharmaceuticals	Pair Corr
0.76	PPERY	Bank Mandiri Persero	Pair Corr
0.62	PPERF	Bank Mandiri Persero	Pair Corr
0.62	BKRKF	PT Bank Rakyat	Pair Corr

Moving against Intellia Stock

0.79	AMLX	Amylyx Pharmaceuticals	Pair Corr
0.72	PRAX	Praxis Precision Med	Pair Corr
0.68	EWTX	Edgewise Therapeutics	Pair Corr
0.64	AKRO	Akero Therapeutics	Pair Corr
0.6	ALVO	Alvotech	Pair Corr
0.46	VRDN	Viridian Therapeutics	Pair Corr
0.43	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.81	WMT	Walmart Aggressive Push	Pair Corr
0.79	T	ATT Inc Aggressive Push	Pair Corr
0.78	SSNLF	Samsung Electronics	Pair Corr
0.78	PTAIF	PT Astra International	Pair Corr
0.71	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr
0.71	BAC	Bank of America Aggressive Push	Pair Corr
0.7	CVX	Chevron Corp Fiscal Year End 7th of February 2025	Pair Corr
0.69	DIS	Walt Disney Aggressive Push	Pair Corr

Related Correlations Analysis

	EDIT	CRBU	CRSP	VERV	BEAM	FATE	VRTX	DNA	PRME	SANA
EDIT		0.03	0.02	0.11	0.25	0.92	0.23	-0.01	0.51	0.79	EDIT
CRBU	0.03		0.82	0.56	0.64	-0.19	0.69	0.28	0.49	-0.2	CRBU
CRSP	0.02	0.82		0.51	0.55	-0.22	0.65	0.45	0.56	-0.28	CRSP
VERV	0.11	0.56	0.51		0.23	-0.12	0.66	0.03	0.62	0.07	VERV
BEAM	0.25	0.64	0.55	0.23		0.11	0.54	0.04	0.24	0.05	BEAM
FATE	0.92	-0.19	-0.22	-0.12	0.11		-0.02	-0.15	0.25	0.82	FATE
VRTX	0.23	0.69	0.65	0.66	0.54	-0.02		0.18	0.64	0.08	VRTX
DNA	-0.01	0.28	0.45	0.03	0.04	-0.15	0.18		0.38	-0.21	DNA
PRME	0.51	0.49	0.56	0.62	0.24	0.25	0.64	0.38		0.39	PRME
SANA	0.79	-0.2	-0.28	0.07	0.05	0.82	0.08	-0.21	0.39		SANA
	EDIT	CRBU	CRSP	VERV	BEAM	FATE	VRTX	DNA	PRME	SANA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

FATE	+ 0.92	EDIT
CRSP	+ 0.82	CRBU
SANA	+ 0.82	FATE
SANA	+ 0.79	EDIT
VRTX	+ 0.69	CRBU
VRTX	+ 0.66	VERV

High negative correlations

SANA	- 0.28	CRSP
FATE	- 0.22	CRSP
SANA	- 0.21	DNA
SANA	- 0.2	CRBU
FATE	- 0.19	CRBU
DNA	- 0.15	FATE

Risk-Adjusted Indicators

There is a big difference between Intellia Stock performing well and Intellia Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Intellia Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
EDIT	3.20	(0.86)	(0.31)	0.00	0.00	7.41	(6.68)	24.40
CRBU	3.75	(0.30)	(0.01)	0.00	0.00	7.42	(6.63)	28.53
CRSP	1.97	(0.17)	(0.02)	0.00	0.00	4.96	(4.61)	16.95
VERV	3.44	(0.18)	(0.05)	0.00	0.00	7.71	(9.25)	22.10
BEAM	3.08	(0.22)	0.02	3.59	(3.59)	7.79	(7.94)	20.75
FATE	3.97	(0.86)	(0.26)	0.00	0.00	8.30	(7.47)	22.40
VRTX	1.29	(0.18)	(0.15)	0.00	0.00	2.30	(3.15)	9.80
DNA	4.41	(0.33)	(0.05)	0.00	0.00	9.31	(10.85)	35.75
PRME	3.91	(0.63)	(0.22)	0.00	0.00	7.07	(9.09)	25.80
SANA	3.32	(1.07)	(0.61)	0.00	0.00	7.20	(8.07)	23.40

Intellia Therapeutics Corporate Management

JD Esq	General VP	Profile
Jennifer Doudna	Founder Board	Profile
Rachel Haurwitz	CoFounder	Profile
Glenn CPA	CFO VP	Profile
Derek Hicks	Executive Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC